Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P37840 6622 SNCA NACP PARK1 Hepatocellular carcinoma Phosphorylation N S9 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma Phosphorylation N S9 P37840 6622 SNCA NACP PARK1 Hepatocellular carcinoma SUMOylation N K10 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma SUMOylation N K10 P37840 6622 SNCA NACP PARK1 Hepatocellular carcinoma SUMOylation N K12 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma SUMOylation N K12 P37840 6622 SNCA NACP PARK1 Hepatocellular carcinoma Ubiquitination N K12 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma Ubiquitination N K12 P37840 6622 SNCA NACP PARK1 Hepatocellular carcinoma Acetylation N K21 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma Acetylation N K21 P37840 6622 SNCA NACP PARK1 Hepatocellular carcinoma SUMOylation N K21 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma SUMOylation N K21 P37840 6622 SNCA NACP PARK1 Hepatocellular carcinoma Ubiquitination N K21 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma Ubiquitination N K21 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma SUMOylation N K23 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma Ubiquitination N K23 P37840 6622 SNCA NACP PARK1 Parkinson's disease Acetylation N K32 P37840 6622 SNCA NACP PARK1 Bladder urothelial carcinoma SUMOylation N K34 P37840 6622 SNCA NACP PARK1 Parkinson's disease SUMOylation N K34 P37840 6622 SNCA NACP PARK1 Bladder urothelial carcinoma Phosphorylation N Y39 P37840 6622 SNCA NACP PARK1 Bladder urothelial carcinoma Phosphorylation N S42 P37840 6622 SNCA NACP PARK1 Parkinson's disease Phosphorylation N S42 P37840 6622 SNCA NACP PARK1 Parkinson's disease Ubiquitination N K43 P37840 6622 SNCA NACP PARK1 Parkinson's disease Acetylation N K58 P37840 6622 SNCA NACP PARK1 Brain lower grade glioma O-linked glycosylation N T75 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma O-linked glycosylation N T75 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma SUMOylation N K80 P37840 6622 SNCA NACP PARK1 Lung adenocarcinoma O-linked glycosylation N T81 P37840 6622 SNCA NACP PARK1 Stomach adenocarcinoma O-linked glycosylation N S87 P37840 6622 SNCA NACP PARK1 Stomach adenocarcinoma Phosphorylation N S87 P37840 6622 SNCA NACP PARK1 Parkinson's disease Acetylation N K96 P37840 6622 SNCA NACP PARK1 Stomach adenocarcinoma Acetylation N K96 P37840 6622 SNCA NACP PARK1 Parkinson's disease SUMOylation N K96 P37840 6622 SNCA NACP PARK1 Stomach adenocarcinoma SUMOylation N K96 P37840 6622 SNCA NACP PARK1 Parkinson's disease SUMOylation N K102 P37840 6622 SNCA NACP PARK1 Parkinson's disease Phosphorylation N Y125 P37840 6622 SNCA NACP PARK1 Parkinson's disease Phosphorylation N S129 P37840 6622 SNCA NACP PARK1 Uterine cancer Phosphorylation N S129 P37840 6622 SNCA NACP PARK1 Parkinson's disease Phosphorylation N Y133 P37840 6622 SNCA NACP PARK1 Skin cutaneous melanoma Phosphorylation N Y133 P37840 6622 SNCA NACP PARK1 Skin cutaneous melanoma Phosphorylation N Y136 P61586 387 RHOA ARH12 ARHA RHO12 Breast adenocarcinoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Ubiquitination N K7 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation C T19 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Ovarian cancer Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Prostate adenocarcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N T19 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation C S26 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Prostate adenocarcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N S26 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal carcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Prostate adenocarcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma SUMOylation N K27 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Hematologic cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Ovarian cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer Ampylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal adenocarcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Hematologic cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Ovarian cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma O-linked glycosylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal adenocarcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N Y34 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Melanoma Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Uterine cancer Phosphorylation N T37 P61586 387 RHOA ARH12 ARHA RHO12 Stomach cancer ADP-ribosylation N N41 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Ectodermal dysplasia Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Esophageal adenocarcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Lung squamous cell carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N Y42 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation C T60 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Inborn genetic diseases Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Pancreatic adenocarcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N T60 P61586 387 RHOA ARH12 ARHA RHO12 Colon adenocarcinoma Phosphorylation C Y66 P61586 387 RHOA ARH12 ARHA RHO12 Ectodermal dysplasia Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Inborn genetic diseases Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Non-Hodgkin's lymphoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Pancreatic adenocarcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Skin cutaneous melanoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Stomach adenocarcinoma Phosphorylation N Y66 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N S88 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N T100 P61586 387 RHOA ARH12 ARHA RHO12 Transitional cell carcinoma Phosphorylation N T100 P61586 387 RHOA ARH12 ARHA RHO12 Uterine corpus endometrial carcinoma Phosphorylation N T100 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Ubiquitination N K104 P61586 387 RHOA ARH12 ARHA RHO12 Transitional cell carcinoma Ubiquitination N K104 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Ubiquitination N K118 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Methylation N K119 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Methylation N R128 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K133 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Ubiquitination N K133 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K135 P61586 387 RHOA ARH12 ARHA RHO12 Lung adenocarcinoma Ubiquitination N K135 P61586 387 RHOA ARH12 ARHA RHO12 Breast invasive carcinoma Ubiquitination N K140 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Ubiquitination N K140 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N Y156 P61586 387 RHOA ARH12 ARHA RHO12 Bladder urothelial carcinoma Phosphorylation N S160 P61586 387 RHOA ARH12 ARHA RHO12 Head and neck squamous cell carcinoma Phosphorylation N S160 P61586 387 RHOA ARH12 ARHA RHO12 Breast cancer tumor tissue Polyubiquitination U 35654587 P37840 6622 SNCA NACP PARK1 Pheochromocytoma PC12 cell line Ubiquitination P 18065497 P61586 387 RHOA ARH12 ARHA RHO12 Colorectal cancer SW480 and SW1116 cells Serotonylation P Q52 37046308 P61586 387 RHOA ARH12 ARHA RHO12 Colorectal cancer SW480 and SW1116 cells Serotonylation P Q63 37046308 P61586 387 RHOA ARH12 ARHA RHO12 Pulmonary hypertension lung tissue Serotonylation U Q63 19299501 P61586 387 RHOA ARH12 ARHA RHO12 Colorectal cancer SW480 and SW1116 cells Serotonylation P Q136 37046308 P37840 6622 SNCA NACP PARK1 Parkinson's disease Ampylation D T33 31034889 P37840 6622 SNCA NACP PARK1 Parkinson's disease Tyrosine phosphorylation U Y39 27348587;28636593;27348587;27348587;28636593;28636593 P37840 6622 SNCA NACP PARK1 Parkinson's disease Ampylation D T54 31034889 P37840 6622 SNCA NACP PARK1 Parkinson's disease Ampylation D T75 31034889 P37840 6622 SNCA NACP PARK1 Huntington's disease Serine phosphorylation U S129 35659303 P37840 6622 SNCA NACP PARK1 Lewy body disease Tyrosine phosphorylation U Y136 34772466 P61586 387 RHOA ARH12 ARHA RHO12 Breast cancer/tumor/carcinoma tumor tissue Phosphorylation U 23324271 P37840 6622 SNCA NACP PARK1 Parkinson's disease cell line SUMOylation D K96 21746851 P37840 6622 SNCA NACP PARK1 Parkinson's disease cell line SUMOylation D K102 21746851 P37840 6622 SNCA NACP PARK1 Parkinson's disease Keynon cells Serine phosphorylation U S129 21562258;21849493;21865317;11813001;12505616;14579119;24204929;11813001;28636593;14579119;12505616;22344688;21562258;25637461;21865317;21849493;34974168;12505616;11813001;14579119;16847063;21562258;21400129;21865317;22344688;25637461;28636593;34220490;34115198;34658833;32156613;31933723;35659116;36179692;35418851;37667227;22344688;25637461;28636593;24204929 P37840 6622 SNCA NACP PARK1 Synucleinopathy Keynon cells Serine phosphorylation U S129 12505616;12505616;16847063 P37840 6622 SNCA NACP PARK1 Parkinson's disease Phosphorylation P 29737566 P37840 6622 SNCA NACP PARK1 Parkinson's disease Threonine phosphorylation P T64 37252975 P37840 6622 SNCA NACP PARK1 Dementia with Lewy bodies Serine phosphorylation D S129 35353605 P37840 6622 SNCA NACP PARK1 Parkinson's disease Serine phosphorylation D S129 35353605 P37840 6622 SNCA NACP PARK1 Alzheimer's disease Serine phosphorylation U S129 19889641 P37840 6622 SNCA NACP PARK1 Dementia with Lewy bodies Serine phosphorylation U S129 35659116;36847016 P37840 6622 SNCA NACP PARK1 Multiple system atrophy Serine phosphorylation U S129 35659116;36304930 P61586 387 RHOA ARH12 ARHA RHO12 Gastric cancer Tyrosine phosphorylation U Y42 31056743;33388549